ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "pregnancy"

  • Abstract Number: L13 • ACR Convergence 2022

    Fetal Cardiac Targets Identify the Autoantibodies Associated with Congenital Heart Block

    Stephanie Benjamin1, Lisa Vi2, Diptendu Chatterjee1, Edgar Jaeggi1, Marie Wahren-Herlenius3, Amelia Ruffatti4, Linda Hiraki5, Michelle Lohbihler2, Lusia Sepiashvili1, Carl Laskin6, Meena Fatah1, Daniela Dominguez5, Lawrence Ng5, Anthony Gramolini2, Vincent Christoffels7, Stephanie Protze2 and Robert Hamilton8, 1Hospital for Sick Children, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3Karolinska Institutet, Stockholm, Stockholms Lan, Sweden, 4Universitå di Padova, Padova, Italy, 5The Hospital for Sick Children, Toronto, ON, Canada, 6Mt. Sinai Hospital/University of Toronto, Toronto, ON, Canada, 7Amsterdam UMC, Amsterdam, Zuid-Holland, Netherlands, 8Hospital for Sick Children, Markham, ON, Canada

    Background/Purpose: Autoimmune congenital heart block (CHB+) affects the fetus of mothers with anti-Ro antibodies. Anti-Ro (Ro+) antibodies (Abs) are usually present in maternal sera when…
  • Abstract Number: 0950 • ACR Convergence 2022

    Obstetric Outcomes in Women with Rheumatic Disease and COVID-19 in the Context of Vaccination Status: Data from the COVID-19 Global Rheumatology Alliance Registry

    Sinead Maguire1, Samar Al emadi2, Paul Alba3, Mathia C Aguiar4, Talal Al Lawati5, Gelsomina Alle6, Bonnie Bermas7, Suleman Bhana8, Branimir Anic9, Inita Bulina10, Megan Clowse11, Adriana Karina Cogo12, Iris Colunga13, Claire Cook14, KAREN JOYCE CORTEZ15, Kathryn Dao16, Milena Gianfrancesco17, Monique Gore-Massy18, Laure Gossec19, Rebecca Grainger20, Jonathan Hausmann21, Tiffany YT Hsu22, Kimme Hyrich23, Carolina Isnardi24, Yumeko Kawano22, Rachael Kilding25, Daria A Kusevich26, Saskia Lawson-Tovey27, Jean Liew28, Eoghan McCarthy29, Anna Montgomery30, Sebastian Moyano3, Noreen Nasir31, IVAN PADJEN32, Charalampos Papagoras33, Naomi Patel34, MARIANA PERA35, Cecilia Pisoni36, Guillermo Pons-Estel37, Antonio Lorenzo Quiambao38, Rosana Quintana39, Eric Ruderman40, Sebastian Sattui41, Veronica Savio42, Savino Sciascia43, Marieta Sencarova44, Rosa Serrano-Morales45, Faizah Siddique46, Emily Sirotich47, Jeffrey Sparks48, Anja Strangfeld49, Paul Sufka50, Helen Tanner51, Yohana Tissera52, Zachary Wallace14, Marina Werner53, Leanna Wise54, Angus Worthing55, JoAnn Zell56, Julija Zepa10, Pedro Machado57, Jinoos Yazdany17, Philip Robinson51 and Richard Conway1,1St James' Hospital, Dublin, Ireland, 2Hamad Medical Corporation, Doha, Qatar, 3Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 4Hospital General Agustin O`Horan, Merida, Mexico, 5Sultan Qaboos University Hospital, Muscat, Oman, 6Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 7UT Southwestern, Dallas, TX, 8Crystal Run Healthcare, Middletown, NY, 9Clinical Hospital Centre Zagreb, School of Medicine, University of Zagreb, Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, Zagreb, Croatia, 10Center of Rheumatology, Paul Stradins Clinical University hospital, Riga, Latvia, 11Duke University, Durham, NC, 12Hospital Interzonal Luis Guemes, Haedo and Hospital San Juan de Dios, Castelar, Buenos Aires, Argentina, 13Hospital Universitario UANL, Monterrey, Mexico, 14Massachusetts General Hospital, Boston, MA, 15Baguio General Hospital Medical Center, Baguio, Philippines, 16UT Southwestern Medical Center, Dallas, TX, 17University of California San Francisco, San Francisco, CA, 18Covid-19 GRA, West Orange, NJ, 19Sorbonne Université, Paris, France, 20University of Otago, Wellington, New Zealand, 21Division of Immunology, Boston Children's Hospital, Boston, MA, 22Brigham and Women's Hospital, Boston, MA, 23The University of Manchester, Manchester, United Kingdom, 24SAR-COVID Coordinator, Research Unit Argentine Society of Rheumatology, Buenos Aires, Argentina, 25Sheffield teaching hospitals trust, Sheffield, United Kingdom, 26VA Nasonova Research Institute of Rheumatology, Moscow and Anikina Clinic, Vidnoe, Russia, 27Centre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, the University of Manchester, Manchester, UK AND National Institute of Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom, 28Boston University, Boston, MA, 29Beaumont Hospital, Dublin, Ireland, 30University of California, San Francisco, USA; San Francisco VA Medical Center, San Francisco, USA, San Francisco, CA, 31Aga Khan University Hospital, Karachi Pakistan, Karachi, Pakistan, 32University Hospital Center Zagreb, Zagreb, Croatia, 33First Department of Internal Medicine and Laboratory of Molecular Hematology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece, 34Massachusetts General Hospital, Sale Creek, TN, 35Hospital Ángel C Padilla, San Miguel de Tucumán, Tucuman, Argentina, 36CEMIC- Centro de Educación Médica e Investigaciones Clínicas, Buenos Aires, Argentina, 37Argentine Society of Rheumatology, Buenos Aires, Argentina, 38East Avenue Medical Center, Quezon City, Philippines, 39Centro Regional de Enfermedades Autoinmunes y Reumáticas. Grupo Oroño (GO CREAR) and Research Unit Argentine Society of Rheumatology, Buenos Aires, Argentina, 40Northwestern University Feinberg School of Medicine, Chicago, IL, 41University of Pittsburg, Pittsburg, Pennsylvania, USA, PIttsburgh, PA, 42Hospital Córdoba; Consultora Integral de Salud CMP, Cordoba, Argentina, 43University of Turin, Torino, Italy, 44Univerzitna nemocnica L Pasteura, Slovakia, Kosice, Slovakia, 45Sanatorio Parque. Centro de Enfermedades Autoinmunes y Reumáticas del Grupo Oroño, Rosario, Argentina, 46Loyola University Medical Center, Elmhurst, IL, 47Department of Health Research, Evidence and Impact, McMaster University, Hamilton, ON, Canada, 48Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 49Deutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany, 50HealthPartners, Eagan, MN,51University of Queensland School of Medicine, Brisbane, Queensland, Australia, 52Internal Medicine Service, Rheumatology Unit, Hospital Córdoba y Sanatorio Parque de Córdoba, Córdoba, Argentina, 53Hospital Nacional de Clínicas, Córdoba, Argentina, 54LAC+USC/Keck Medicine of USC, Pasadena, CA, 55Arthritis & Rheumatism Associates, PC, Washington, DC, 56University of Colorado Anschutz Medical Campus, Aurora, CO, 57Centre for Rheumatology & Department of Neuromuscular Diseases, University College London and National Institute for Health Research (NIHR), University College London Hospitals NHS Foundation Trust, and Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, London, United Kingdom

    Background/Purpose: To describe obstetric outcomes based on COVID-19 vaccination status in women with rheumatic and musculoskeletal diseases (RMDs) who developed COVID-19 during pregnancy.Methods: We extracted…
  • Abstract Number: 0969 • ACR Convergence 2022

    Use of Gonadotropin-releasing Hormone Agonists for Ovarian Preservation in Patients Receiving Cyclophosphamide for Systemic Lupus Erythematosus: A Meta-analysis

    Komal Ejaz1, Dania Abid2, Paul Juneau3, Jun Chu4 and Sarfaraz Hasni5, 1The Wright Center for Graduate Medical Education, Scranton, PA, 2Idaho College of Osteopathic Medicine, Meridian, ID, 3National Institutes of Health Library, Bethesda, MD, 4National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, 5National Institutes of Health, Bethesda, MD

    Background/Purpose: Cyclophosphamide (CYC) has known cytotoxic effects on ovarian reserve and has been linked to premature ovarian failure in systemic lupus erythematosus (SLE). The concurrent…
  • Abstract Number: 0952 • ACR Convergence 2022

    Pregnancy Course and Outcomes of Patients with Polymyositis and Dermatomyositis (PM/DM) in Our Institution

    Rina Mino1, Hiromi Shimada2, Risa Wakiya2, shusaku nakashima3, Mikiya Kato2, taichi miyagi4, Yusuke Ushio5, Kanako Chujo6, Tomohiro Kameda2 and Hiroaki Dobashi7, 1Kagawa University, Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Miki-cho, Kita-gun, Japan, 2Kagawa University, Kagawa, Japan, 3Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa, Japan, 4Kagawa University, Kidagun, Japan, 5Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Miki, Kita District, Kagawa, Japan, 6Kagawa University, Miki, Kita District, Kagawa, Japan, 7Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa, Kagawa, Japan

    Background/Purpose: The purpose of this study is to determine the association between changes in disease activity during pregnancy and pregnancy outcome by analyzing a case…
  • Abstract Number: 1335 • ACR Convergence 2022

    Artificial Intelligence–enabled Sentiment Analysis of Public Attitude Toward Pregnancy in Lupus Social Media Group

    Gopisree Peringeth1 and Milena Vukelic2, 1Jacobi Medical Center/Albert Einstein College of Medicine, New York, NY, 2Albert Einstein College of Medicine, New York, NY

    Background/Purpose: Lupus commonly affects women of reproductive age whose pregnancies are associated with higher rates of complications and fetal loss. There is a knowledge gap…
  • Abstract Number: 0953 • ACR Convergence 2022

    Increased Risk of Preterm Delivery Phenotypes and Hypertensive Disorders of Pregnancy in First Deliveries of Patients with Systemic Vasculitis

    Audra Horomanski1, Gary Shaw2, Jonathan Mayo3 and Julia Simard4, 1Stanford University, Stanford, CA, 2Stanford University School of Medicine, Palo Alto, 3Stanford University, Stanford, 4Stanford University School of Medicine, Palo Alto, CA

    Background/Purpose: Systemic vasculitides are rare disorders characterized by vascular inflammation that can affect virtually every organ system. Recent treatment advances have increased life expectancy and…
  • Abstract Number: 1465 • ACR Convergence 2022

    Clinical Profiling and Antiphospholipid Antibody (aPL) Associations in Indian Systemic Lupus Erythematosus (SLE) Cohort

    Vineeta Shobha1, Liza Rajasekhar2, Sandra Manuel1, Chengappa Kavadichanda3, Ashish J Mathew4, Ranjan Gupta5, Manish Rathi6, Parasar Ghosh7, Saumya Ranjan Tripathy8, Avinash Jain9 and Amita Aggarwal10, 1St. John’s Medical College Hospital, Bangalore, India, 2Nizam's Institute of Medical Sciences, Madhapur, India, 3JIPMER, Pondicherry, Puducherry, India, 4Rigshospitalet, Copenhagen, Denmark, 5All India Institute of Medical Sciences, New Delhi, India, 6PGIMER Chandigarh, Chandigarh, India, 7Govt of West Bengal, Kolkata, India, Kolkata, West Bengal, India, 8SCB medical college, Cuttack, India, 9SMS Medical College, Lucknow, India, 10Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

    Background/Purpose: Antiphospholipid Antibody (aPL) are described in 11-40% of patients with SLE. Whether the presence of any of the aPLs or combinations thereof, can accurately…
  • Abstract Number: 0954 • ACR Convergence 2022

    What Drives the BASDAI in Pregnant Patients with Axial Spondyloarthritis? A Pooled Analysis of Four European Pregnancy Registries

    Yvette Meissner1, Nathalie Costedoat-Chalumeau2, Rebecca Fischer-Betz3, Frauke Foerger4, Anna Molto5, Marianne Wallenius6 and Anja Strangfeld1, 1Deutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany, 2Inserm DR Paris 5, Paris, France, 3Uniklinik Duesseldorf, Duesseldorf, Germany, 4Inselspital Bern, Bern, Switzerland, 5Rheumatology Department, Cochin Hospital, APHP, Paris, France, 6St. Olav University Hospital, Trondheim, Norway

    Background/Purpose: The patient reported Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) includes the six components fatigue, neck, back or hip pain, pain or swelling in…
  • Abstract Number: 1616 • ACR Convergence 2022

    Drug Use and Pregnancy Outcomes in Pregnant Women with Systemic Vasculitis: A Nation Wide Cohort Study

    Camille Mettler1, Nathanaël Beeker2, Mathis Collier2, Veronique Le Guern3, Benjamin Terrier4 and Laurent Chouchana5, 1Department of Internal Medicine, National Referral Center for Rare Systemic and Autoimmune Diseases, Cochin Hospital, Paris, France, 2Unité de Recherche clinique, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France, 3Hôpital Cochin, Paris, France, 4National Referral Center for Rare Systemic Autoimmune Diseases, Cochin Hospital, Paris, France, 5Pharmacology department, Centre Régional de Pharmacovigilance, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France

    Background/Purpose: Women of childbearing age are rarely affected by systemic vasculitis (SV), explaining the lack of solid data regarding pregnancy in these patients. The objective…
  • Abstract Number: 0955 • ACR Convergence 2022

    Unfavorable Pregnancy Outcome Is Significantly Associated with Corticosteroid Exposure During Pregnancy in Women with RA: Analysis of the Prospective GR2 Cohort

    SABRINA HAMROUN1, Marion Couderc2, Rene-Marc Flipo3, Laure Gossec4, Christophe Richez5, Rakiba Belkhir6, Aline Frazier-Mironer7, Valerie Devauchelle8, Hubert Marotte9, Jérémie SELLAM10, elisabeth gervais11, Alban DEROUX12, Cédric Lukas13, Emmanuelle Dernis14, Emmanuel Chatelus15 and Anna Molto16, 1Rheumatology Department, University Hospital of Cochin, Paris, Paris, France, 2University Hospital, Clermont-Ferrand, France, 3CHU Lille, Boulogne-Billancourt, France, 4Sorbonne Université, Paris, France, 5Université de Bordeaux, Bordeaux, France, 6Rheumatology departement, Bicêtre, Paris-Saclay university, Le Kremlin Bicêtre, France, 7APHP Hôpital Lariboisire, Paris, France, 8Université de Bretagne Occidentale, Brest, France, 9INSERM 1059, Saint-Etienne, France, 10Sorbonne Universite, AP-HP, Saint-Antoine hospital, Paris, France, 11chu poitiers, Poitiers, France, 12CHU Grenoble, Grenoble, France, 13University Hospital Centre Montpellier, University of Montpellier, Montpellier, France, 14LE MANS general hospital, LE MANS, France, 15University Hospital of Strasbourg, Strasbourg, France, 16Rheumatology Department, Cochin Hospital, APHP, Paris, France

    Background/Purpose: Rheumatoid arthritis (RA) is one of the most common chronic inflammatory diseases and regularly affects women of childbearing age. However, there is limited knowledge…
  • Abstract Number: 1672 • ACR Convergence 2022

    The Impact of Systemic Sclerosis (SSc) on Women’s Health Evaluated with a New SSc-specific Patient-reported Questionnaire

    Maria Grazia Lazzaroni1, Liala Moschetti1, Eleonora Pedretti1, Andrea Lojacono2, Francesca Ramazzotto3, Cristina Zanardini3, Zatti Sonia3, Angela Tincani4, Franco Franceschini1, Paolo Airò5 and Laura Andreoli1, 1Rheumatology and Clinical Immunology Unit, ASST Spedali Civili and University of Brescia, Brescia, Italy, 2Obstetrics and Gynecology, ASST Garda, Desenzano del Garda, Brescia, Brescia, Italy, 3Obstetrics and Gynecology, ASST Spedali Civili and University of Brescia, Brescia, Italy, 4Rheumatology and Clinical Immunology Unit, ASST Spedali Civili and University of Brescia, Gussago, Italy, 5Rheumatology and Clinical Immunology Unit, ASST Spedali Civili, Brescia, Italy

    Background/Purpose: Systemic Sclerosis (SSc) has a strong female predominance and can significantly impair the everyday quality of life of patients. We aimed at designing a…
  • Abstract Number: 0956 • ACR Convergence 2022

    Contribution of Antibody Titers/Specificities to Adverse Pregnancy Outcomes in a Multicenter Prospective Study of anti-Ro Positive Mothers

    Nicola Fraser1, Mala Masson2, Kristina Deonaraine3, Philip Carlucci4, Colin Phoon5, Ashley Roman5, Peter Izmirly6, Amit Saxena5, Michael Belmont6, Christina Penfield5, Young Mi Lee5, Julie Nusbaum7, Bruce Solitar5, Fardina Malik5, Paula Rackoff1, Rebecca Haberman1, Ruben Acherman8, Elena Sinkovskaya9, Alfred Albuhamad9, Majd Makhoul10, Gary Satou11, Nelangi Pinto12, Anita Moon-Grady13, Lisa Howley14, Stephanie Levasseur15, Jyothi Matta16, Christopher Lindblade17, Andrew Rubenstein18, Caitlin Haxel19, Katherine Kohari20, Joshua Copel20, James Strainic21, Tam Doan22, Karla Bermudez-Wagner22, Shreya Sunil Sheth22, Stacy Killen23, Theresa Tacy24, Michelle Kaplinski24, Bailey Drewes25, Robert Clancy6, Bettina Cuneo26 and Jill Buyon6, 1NYU School of Medicine, New York, NY, 2NYU Langone Medical Center- Division of Rheumatology, New York, NY, 3University at Buffalo, Buffalo, NY, 4NYU Langone, New York, NY, 5NYU Langone Health, New York, NY, 6NYU Grossman School of Medicine, New York, NY, 7NYU Long Island School of Medicine, Mineola, NY, 8Children's Heart Center, Las Vegas, 9East Virginia Medical School, Norfolk, VA, 10University of Kentucky, Lexington, KY, 11University of California Los Angeles, Los Angeles, CA, 12University of Utah, Salt Lake City, 13UCSF, San Francisco, 14Midwest Fetal Care Center, Children's Minnesota/Allina Health, Minneapolis, MN, 15Columbia University, New York, NY, 16University of Louisville, Louisville, KY, 17Phoenix Children's Hospital, Phoenix, 18Dignity Health, Phoenix, 19University of Vermont Children's Hospital, Burlington, VT, 20Yale University, New Haven, CT, 21UH Rainbow Babies, Cleveland, OH, 22Baylor College of Medicine, Houston, TX, 23Vanderbilt University, Nashville, TN, 24Stanford University, Stanford, CA, 25University of Colorado, Denver, CO, 26University of Colorado School of Medicine, Aurora, CO

    Background/Purpose: While it is well accepted that congenital heart block (CHB) and neonatal annular rash are highly associated with maternal anti-Ro60 and 52 autoantibodies, the…
  • Abstract Number: 1673 • ACR Convergence 2022

    Preconceptional NSAID Treatment Exposure Is Associated with a Significantly Longer Time-to-conception in Women with Spondyloarthritis: Analysis of the Prospective GR2 Cohort

    SABRINA HAMROUN1, Marion Couderc2, Rene-Marc Flipo3, Jérémie SELLAM4, Christophe Richez5, Emmanuelle Dernis6, Aline Frazier-Mironer7, Laure Gossec8, elisabeth gervais9, Hubert Marotte10, Laetitia Dunogeant11, Cédric Lukas12, Alban DEROUX13, Nathalie Costedoat-Chalumeau14 and Anna Molto15, 1Rheumatology Department, University Hospital of Cochin, Paris, Paris, France, 2University Hospital, Clermont-Ferrand, France, 3CHU Lille, Boulogne-Billancourt, France, 4Sorbonne Universite, AP-HP, Saint-Antoine hospital, Paris, France, 5Université de Bordeaux, Bordeaux, France, 6LE MANS general hospital, LE MANS, France, 7APHP Hôpital Lariboisire, Paris, France, 8Sorbonne Université, Paris, France, 9chu poitiers, Poitiers, France, 10INSERM 1059, Saint-Etienne, France, 11Hospital of Aix en Provence, Marseille, France, 12University Hospital Centre Montpellier, University of Montpellier, Montpellier, France, 13CHU Grenoble, Grenoble, France, 14Inserm DR Paris 5, Paris, France, 15Rheumatology Department, Cochin Hospital, APHP, Paris, France

    Background/Purpose: Spondyloarthritis (SpA) is one of the most common chronic inflammatory diseases and regularly affects women of childbearing age. However, there is limited knowledge about…
  • Abstract Number: 0957 • ACR Convergence 2022

    Timeliness of Fetal Echocardiography for Congenital Heart Block Detection in Anti-Ro/La-Positive Pregnancies

    Amanda Ohayon1, Nikola Wilk1, Arielle Mendel2, Mayssa Moukarzel1, Jessica Simoneau1, Wadi Mawad1, Gabriel Altit1 and Evelyne Vinet2, 1McGill University Health Center, Montréal, QC, Canada, 2McGill University Health Centre, Montréal, QC, Canada

    Background/Purpose: Best practice guidelines recommend screening for congenital heart block (CHB) in anti-Ro/La-positive pregnancies with serial echocardiography starting between 16 to 18 weeks of gestational…
  • Abstract Number: 1674 • ACR Convergence 2022

    In Utero Exposure to Hydroxychloroquine Does Not Associate with Ocular Toxicity as Assessed by Optical Coherence Tomography Five Years After Birth

    Peter Izmirly1, Mala Masson2, Michael Marmor3, Noel Zahr4, Nathalie Costedoat-Chalumeau5 and Jill Buyon1, 1NYU Grossman School of Medicine, New York, NY, 2NYU Langone Medical Center- Division of Rheumatology, New York, NY, 3Stanford University, Stanford, CA, 4Pitié-Salpêtrière Hospital, Paris, France, 5Inserm DR Paris 5, Paris, France

    Background/Purpose: The preventive approach to congenital heart block with hydroxychloroquine (HCQ) [PATCH] study supported the efficacy of HCQ to reduce the recurrence rate of cardiac…
  • 1
  • 2
  • 3
  • …
  • 12
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences